Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03299894
Other study ID # CHRO 2017-06
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 12, 2017
Est. completion date June 10, 2018

Study information

Verified date July 2018
Source Centre Hospitalier Régional d'Orléans
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The delayed administration of an adequate antimicrobial therapy is a strong predictor of impaired outcome in patients with bacterial sepsis. Therefore, the current Surviving Sepsis Campaign guidelines (2016) recommend that administration of intravenous antimicrobials be initiated within one hour following the recognition of sepsis or septic shock.

The quick Sepsis-related Organ Failure Assessment (qSOFA) score is a new bedside tool which has been recently proposed by the Third International Sepsis Consensus Definitions Task Force (Sepsis-3) to identify patients with suspected infection who are at greater risk for a poor outcome outside the Intensive Care Unit (ICU). It uses three criteria, assigning one point for low systolic blood pressure (SBP ≤100 mmHg), high respiratory rate (≥22 breaths per min) and altered mentation (Glasgow coma scale <15). The score ranges from 0 to 3 points. A qSOFA value ≥2 points is associated with a greater risk of death or prolonged ICU stay, these outcomes being more common in infected patients who may be septic than in those with uncomplicated infection. The definite goal of qSOFA is to hasten the management and thus improve the outcome of patients at risk of sepsis or septic shock.

Many patients admitted to the hospital for bacterial sepsis or septic shock are initially managed in the Emergency Department (ED). This study aims at investigating whether the routine calculation of qSOFA at patient triage may hasten the initiation of antimicrobial therapy in patients admitted to the ED with suspected or proven bacterial infection, especially in those with subsequent criteria for sepsis or septic shock (Sepsis-3 definition).


Recruitment information / eligibility

Status Completed
Enrollment 780
Est. completion date June 10, 2018
Est. primary completion date June 10, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 105 Years
Eligibility Inclusion Criteria:

• Suspected or proven bacterial infection at emergency department triage

Exclusion Criteria:

- Imminent death

- Pregnancy

- Breast-feeding

- For patients managed by a medicalized pre-hospital emergency team before ED admission : administration of a first dose of antimicrobial agent before ED admission

- Lack of coverage by the public health insurance system

- Patient's refusal for study enrollment

- Lack of confirmed bacterial infection (i.e., documented either clinically, microbiologically or by imaging procedures) in patients with a suspected bacterial infection at emergency departement triage

Study Design


Intervention

Procedure:
systematic calculation of qSOFA
calculation of qSOFA for each patient

Locations

Country Name City State
France Regional Hospital center of Orleans Orléans

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Régional d'Orléans

Country where clinical trial is conducted

France, 

References & Publications (1)

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of patients who receive a first dose of antimicrobial agent Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) who receive a first dose of antimicrobial agent within one hour following triage in the emergency department. one hour
Secondary Proportion of patients who receive a first dose of adequate antimicrobial agent Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) and microbiologically documented infection who receive a first dose of adequate antimicrobial agent within one hour following triage in the emergency department. one hour
Secondary Proportion of patients who receive a first dose of antimicrobial agent Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) who receive a first dose of antimicrobial agent within 3 hours following triage in the emergency department. three hours
Secondary Proportion of patients who receive a first dose of adequate antimicrobial agent Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) and a microbiologically documented infection who receive a first dose of adequate antimicrobial agent within 3 hours following triage in the emergency department three hours
Secondary Proportion of patients with a decrease in SOFA score value = 1 point Proportion of patients with a decrease in SOFA score value = 1 point between triage in the emergency department (Day 0) and Day 2 among those with an initial SOFA score value = 1 point two days
Secondary Proportion of patients requiring an admission to the Intensive Care Unit Proportion of patients requiring an admission to the Intensive Care Unit between triage in the emergency department (Day 0) and Day 2 two days
Secondary In-hospital mortality at day 7 Number of patients who died in hospital at day 7 seven days
Secondary Overall In-hospital mortality Number of patients who died in hospital during the hospital stay through hospital discharge, up to 3 months
Secondary Length of hospital stay Number of days in hospital throught hospital discharge, up to 3 months
See also
  Status Clinical Trial Phase
Completed NCT00487097 - The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients N/A
Completed NCT01997931 - The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients N/A
Recruiting NCT04926220 - Dynamic Estimation of Cardiac Output in the Operating Room
Not yet recruiting NCT03617796 - Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
Withdrawn NCT04554264 - Complicated Grief in ICU in the Aftermath of COVID-19 N/A
Recruiting NCT02587273 - The Pharmacokinetics of Fentanyl in Intensive Care Patients Phase 4
Withdrawn NCT01749488 - The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care N/A
Recruiting NCT06110390 - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients N/A
Completed NCT04186611 - Early Occupational Therapy in Intensive Care: Feasibility of Implementation N/A
Recruiting NCT03777150 - Is There a Benefit of Postoperative ICU Management After Elective Surgery in Critical Ill Patients? N/A
Completed NCT02583321 - Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate N/A
Completed NCT00787098 - Investigating Modes of Progressive Mobility Phase 2
Recruiting NCT04114747 - Renal Physiology During Continuous Renal Replacement Therapy N/A
Completed NCT02476591 - Charge Transparency in Critical Care Practice and Its Effects on Overall Cost of Care N/A
Completed NCT05795777 - Examination of the Pressure Ulcers in Intensive Care Patients.
Terminated NCT02587130 - Ketamine and Refractory Painful Care in a Palliative Unit Phase 4
Completed NCT02463123 - Energy Expenditure Estimation in Cardiac Surgery N/A
Completed NCT01607723 - "NAVA-PAV" Study: a Cross-over Comparative Study of 2 Advanced Modes Phase 3
Completed NCT01346813 - Epidemiology of Painful Procedures in Neonates N/A
Completed NCT00410852 - Efficacy and Safety of Three Insulin Protocols in Medical Intensive Care Unit Patients N/A